| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease JP Hugot, M Chamaillard, H Zouali, S Lesage, JP Cézard, J Belaiche, ... Nature 411 (6837), 599-603, 2001 | 7182 | 2001 |
| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 5139 | 2015 |
| ESMO consensus guidelines for the management of patients with metastatic colorectal cancer E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ... Annals of Oncology 27 (8), 1386-1422, 2016 | 3764 | 2016 |
| KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer A Lievre, JB Bachet, D Le Corre, V Boige, B Landi, JF Emile, JF Côté, ... Cancer research 66 (8), 3992-3995, 2006 | 2866 | 2006 |
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ French, ... New England Journal of Medicine 349 (3), 247-257, 2003 | 2780 | 2003 |
| Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression E Becht, NA Giraldo, L Lacroix, B Buttard, N Elarouci, F Petitprez, J Selves, ... Genome biology 17, 1-20, 2016 | 2770 | 2016 |
| Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective … W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ... The lancet oncology 11 (8), 753-762, 2010 | 2645 | 2010 |
| KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab A Lievre, JB Bachet, V Boige, A Cayre, D Le Corre, E Buc, M Ychou, ... Journal of clinical oncology 26 (3), 374-379, 2008 | 1972 | 2008 |
| Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value L Marisa, A de Reyniès, A Duval, J Selves, MP Gaub, L Vescovo, ... PLoS medicine 10 (5), e1001453, 2013 | 1459 | 2013 |
| Mapping of a susceptibility locus for Crohn's disease on chromosome 16 JP Hugot, P Laurent-Puig, C Gower-Rousseau, JM Olson, JC Lee, ... Nature 379 (6568), 821-823, 1996 | 1355 | 1996 |
| Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets S Boyault, DS Rickman, A De Reyniès, C Balabaud, S Rebouissou, ... Hepatology 45 (1), 42-52, 2007 | 1314 | 2007 |
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013 | 1312 | 2013 |
| Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up G Argilés, J Tabernero, R Labianca, D Hochhauser, R Salazar, T Iveson, ... Annals of Oncology 31 (10), 1291-1305, 2020 | 1129 | 2020 |
| Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ... British journal of cancer 85 (5), 692-696, 2001 | 1120 | 2001 |
| Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability B Mlecnik, G Bindea, HK Angell, P Maby, M Angelova, D Tougeron, ... Immunity 44 (3), 698-711, 2016 | 1030 | 2016 |
| Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC J Zucman‐Rossi, E Jeannot, JT Van Nhieu, JY Scoazec, C Guettier, ... Hepatology 43 (3), 515-524, 2006 | 881 | 2006 |
| Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer P Laurent-Puig, A Cayre, G Manceau, E Buc, JB Bachet, T Lecomte, ... Journal of clinical oncology 27 (35), 5924-5930, 2009 | 877 | 2009 |
| Alleles of the APC gene: an attenuated form of familial polyposis L Spirio, S Olschwang, J Groden, M Robertson, W Samowitz, G Joslyn, ... Cell 75 (5), 951-957, 1993 | 791 | 1993 |
| Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis P Laurent–Puig, P Legoix, O Bluteau, J Belghiti, D Franco, F Binot, ... Gastroenterology 120 (7), 1763-1773, 2001 | 681 | 2001 |
| Quantitative and sensitive detection of rare mutations using droplet-based microfluidics D Pekin, Y Skhiri, JC Baret, D Le Corre, L Mazutis, CB Salem, F Millot, ... Lab on a Chip 11 (13), 2156-2166, 2011 | 677 | 2011 |
julien Taiebprofessor of medecine Hopital Europeen Georges Pompidou, Université de Paris (Paris-DescartesVerified email at egp.aphp.fr
